Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis — Silvia Calabria (2016) | RDL Network
Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
Article 2016 en
Authors
SC
Silvia Calabria
EC
Elisa Cinconze
MR
Maurizio Rossini
Abstract
1 min read
In a huge clinical practice sample, this study highlights suboptimal adherence to first-line AODs and to supplements and important determinants, such as concomitant therapies.
Tatjana Potpara, Bogdan Markovic, Marek Grygier, Simonetta Genovesi, Apostolos Tzikas, Serge Bovéda, Jens Erik Nielsen‐Kudsk, Giuseppe Boriani, Professor Gregory Lip, A. John Camm
G. Denise Zielinski, Nienke van Rein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, F.J.M. van der Meer, Menno V. Huisman, Suzanne C. Cannegieter, Willem M. Lijfering
Discussion(0)
No comments yet. Be the first to comment.